 niacin clinic observ import underutil drug studi object efficaci side effect niacin therapi dyslipidem individu design retrospect analysi patient chart set outpati referral-bas clinic treatment lipid disord patient patient dyslipidemia niacin atherosclerosi detect prevent clinic subgroup dyslipidem heart transplant recipi result niacin nontranspl group averag dose g/day similar benefici lipoprotein effect transplant nontranspl patient high-dens lipoprotein cholesterol hdl-c respons niacin therapi independ baselin hdl-c level transplant group patient treatment hyperglycemia promin patient pretreat diabet patient sustained-releas niacin case hepat therapi low niacin dose sever differ sustained-releas prepar respons phenomenon caus contamin prepar case hepat patient regular niacin case hepat patient type niacin data substitut prepar immediate-releas niacin famili predisposit hepat occurr side effect ident twin brother sister pharmaci survey pharmacist unawar relationship sustained-releas niacin hepat neg impress regular niacin stock formul small sampl patient niacin lovastatin effect drug combin side effect niacin conclus experi fact regular niacin use lipid-modifi drug patient adequ dose prolong period meaning result certain amount physician skill patient motiv use sustained-releas prepar problem harm consequ strict medic supervis opinion avail sustained-releas niacin nonprescript drug unjustifi reduct very-low-dens lipoprotein cholesterol vldl-c niacin elev low-dens lipoprotein cholesterol mani patient mechan niacin lower vldl-c total cholesterol result decreas synthesi vldl-c